A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia.

A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia. Clin Cancer Res. 2019 08 15; 25(16):4907-4916.

View in: PubMed

subject areas

Adult
Aged
Female
Humans
Male
Middle Aged
Multiple Myeloma
Neoplasm Metastasis
Neoplasm Staging
Oligopeptides
Proteasome Inhibitors
Severity of Illness Index
Treatment Outcome
Waldenstrom Macroglobulinemia

authors with profiles

Andrzej Jakubowiak